
Aura Biosciences
Developing a new class of therapies to target and destroy cancer cells selectively.
Market cap
$400m
Enterprise value
$241m
Share price
$6.43 AURA
Authorizing premium user...
Developing a new class of therapies to target and destroy cancer cells selectively.